Effect of ARMS2 gene polymorphism on intravitreal ranibizumab treatment for neovascular age-related macular degeneration. [electronic resource]
Producer: 20170302ISSN:- 1676-5680
- Female
- Gene Frequency
- Genetic Markers -- genetics
- Humans
- Immunologic Factors -- administration & dosage
- Intravitreal Injections
- Macular Degeneration -- drug therapy
- Male
- Polymorphism, Genetic
- Precision Medicine
- Proteins -- genetics
- Ranibizumab -- administration & dosage
- Sequence Analysis, DNA -- methods
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.